Shire PLC (LON:SHP)’s share price shot up 0.4% during trading on Wednesday . The company traded as high as GBX 3,877.50 ($50.98) and last traded at GBX 3,836.50 ($50.44). 1,711,047 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 2,734,760 shares. The stock had previously closed at GBX 3,820.50 ($50.23).
A number of brokerages have commented on SHP. Liberum Capital reaffirmed a “hold” rating and issued a GBX 4,900 ($64.42) price target on shares of Shire PLC in a research note on Wednesday, June 28th. Goldman Sachs Group, Inc. (The) decreased their price target on Shire PLC from GBX 6,800 ($89.40) to GBX 6,400 ($84.14) and set a “conviction-buy” rating on the stock in a research note on Wednesday, June 28th. Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 5,350 ($70.34) price target on shares of Shire PLC in a research note on Tuesday, June 27th. Deutsche Bank AG reaffirmed a “buy” rating and issued a GBX 6,000 ($78.89) price target on shares of Shire PLC in a research note on Tuesday, June 27th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Shire PLC in a research note on Tuesday, June 27th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of GBX 5,829.67 ($76.65).
The company also recently disclosed a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a dividend of GBX 3.85 ($0.05) per share. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.1%.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.com-unik.info/2017/10/13/shire-plc-shp-shares-up-0-4.html.
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
What are top analysts saying about Shire PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Shire PLC and related companies.